Current status of angiogenesis inhibitors combined with radiation therapy
- 31 August 2006
- journal article
- research article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 32 (5), 348-364
- https://doi.org/10.1016/j.ctrv.2006.03.006
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Angiogenesis in life, disease and medicineNature, 2005
- Cooperative Antitumor Effect of Multitargeted Kinase Inhibitor ZD6474 and Ionizing Radiation in GlioblastomaClinical Cancer Research, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- ZD6474, a Potent Inhibitor of Vascular Endothelial Growth Factor Signaling, Combined With RadiotherapyClinical Cancer Research, 2004
- Pathophysiological Effects of Vascular Endothelial Growth Factor Receptor-2-Blocking Antibody plus Fractionated Radiotherapy on Murine Mammary TumorsCancer Research, 2004
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004
- Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endotheliumInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: Potentiation by irradiationInternational Journal of Cancer, 2003
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971